Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Single Dose Study of MK8266 (8266-001)

This study has been completed.
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp. Identifier:
First received: December 3, 2009
Last updated: June 23, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2010
  Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)